FDA Warns of Liver Damage Risk for Videx
The Food and Drug Administration warned that patients taking Videx, a Bristol Myers Squibb drug for HIV could be at risk for a rare liver disorder. The FDA said it recieved 42 reports of non-cirrhotic portal hypertension over an 19-year period.
Credit: Market News Video
Copyright: Market News Video
Published by Grab Networks
A resource for website publishers who want to embed quality, licensed content on a wide variety of topics. View profile
